| Dr Juliana Youngmin Park, MD | |
|
3020 Hamaker Ct, Suite B-103, Fairfax, VA 22031-2238 | |
| (703) 573-9688 | |
| (703) 207-9396 |
| Full Name | Dr Juliana Youngmin Park |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 33 Years |
| Location | 3020 Hamaker Ct, Fairfax, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790864940 | NPI | - | NPPES |
| 340868 | Other | VA | ALLIANCE |
| 5357721 | Other | VA | AETNA |
| F051-0001 | Other | VA | CAREFIRST |
| 1031145 | Other | VA | FIRSTHEALTH,MAILHANDLERS, |
| 140964 | Other | VA | ANTHEM & BCBS FEDERAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 010154277 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Entity Name | Juliana Y. Park Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013197755 PECOS PAC ID: 5597938175 Enrollment ID: O20111026000503 |
News Archive
Today, there is only one class of antiviral medicines against herpesviruses - a family of viruses that cause mononucleosis, herpes, and shingles, among other illnesses - meaning options for treating these infections are limited. If viruses become resistant to these frontline treatments, a growing problem particularly in clinical settings, there are no alternative drugs to serve as backup.
Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy. Recommendations for the use of the most common forms of UV light therapy, as stand-alone treatments or in conjunction with other therapies, were outlined, including patient considerations.
American Pharmaceutical Partners announced today that February 8, 2005 is the launch date of Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound). Abraxane will be marketed by the national sales force of Abraxis Oncology, APP's proprietary sales and marketing division.
The study by researchers from the Department of Neurology at the University of Ulsan College of Medicine in Seoul showed that herpes zoster infection not only raised the risk of ischaemic and haemorrhagic stroke but also that of a transient ischaemic attack (TIA), a warning mini-stroke often preceding a full-blown stroke.
By combining two powerful technologies, scientists are taking diabetes research to a whole new level. In a study led by Harvard University's Kevin Kit Parker, microfluidics and human, insulin-producing beta cells have been integrated in an "Islet-on-a-Chip".
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Juliana Youngmin Park, MD 3020 Hamaker Ct, Suite B-103, Fairfax, VA 22031-2238 Ph: (703) 573-9688 | Dr Juliana Youngmin Park, MD 3020 Hamaker Ct, Suite B-103, Fairfax, VA 22031-2238 Ph: (703) 573-9688 |
News Archive
Today, there is only one class of antiviral medicines against herpesviruses - a family of viruses that cause mononucleosis, herpes, and shingles, among other illnesses - meaning options for treating these infections are limited. If viruses become resistant to these frontline treatments, a growing problem particularly in clinical settings, there are no alternative drugs to serve as backup.
Based on an extensive review of the highest quality scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis with ultraviolet (UV) light therapy, also known as phototherapy. Recommendations for the use of the most common forms of UV light therapy, as stand-alone treatments or in conjunction with other therapies, were outlined, including patient considerations.
American Pharmaceutical Partners announced today that February 8, 2005 is the launch date of Abraxane for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound). Abraxane will be marketed by the national sales force of Abraxis Oncology, APP's proprietary sales and marketing division.
The study by researchers from the Department of Neurology at the University of Ulsan College of Medicine in Seoul showed that herpes zoster infection not only raised the risk of ischaemic and haemorrhagic stroke but also that of a transient ischaemic attack (TIA), a warning mini-stroke often preceding a full-blown stroke.
By combining two powerful technologies, scientists are taking diabetes research to a whole new level. In a study led by Harvard University's Kevin Kit Parker, microfluidics and human, insulin-producing beta cells have been integrated in an "Islet-on-a-Chip".
› Verified 4 days ago
Dr. David Benjamin Summer, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3031 Javier Rd, Suite 300, Fairfax, VA 22031 Phone: 703-698-8880 Fax: 703-698-8884 | |
Dr. James W Slack, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 12255 Fair Lakes Parkway, Fairfax, VA 22033 Phone: 703-934-5820 Fax: 703-934-5290 | |
Dr. John C Baldinger, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3025 Hamaker Ct Ste 101, Fairfax, VA 22031 Phone: 703-876-9630 Fax: 703-876-0163 | |
Dr. Minh-phuong Lu Doan, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 12255 Fair Lakes Pkwy, Kaiser Permanente, Fairfax, VA 22033 Phone: 702-934-5700 | |
Dr. Kristen Elizabeth Dunbar, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3998 Fair Ridge Dr Ste 105, Fairfax, VA 22033 Phone: 571-349-2191 Fax: 571-349-2211 | |
John William Josephson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3998 Fair Ridge Dr Ste 105, Fairfax, VA 22033 Phone: 571-349-2191 Fax: 571-349-2211 | |
Dr. Jonathan Taylormoore, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 3023 Hamaker Ct Ste 500, Fairfax, VA 22031 Phone: 703-876-2788 Fax: 571-776-3190 |